uTomo Platform Development
Neurological and Psychiatric Conditions (Digital Biomarkers/Diagnostics)
Pre-clinicalActive
Key Facts
Indication
Neurological and Psychiatric Conditions (Digital Biomarkers/Diagnostics)
Phase
Pre-clinical
Status
Active
Company
About XENSE
XENSE is an early-stage, private AI/ML diagnostics company targeting the neurology and psychiatry markets with its uTomo platform for advanced X-ray imaging. The company is in a pre-revenue, pre-clinical development stage and is currently raising capital from accredited investors via platforms like Wefunder and StartEngine. Leadership includes founder Ying Zhao as CEO/CTO and Dr. Sean Lavine heading Medical Affairs, indicating a blend of technical and clinical expertise. The primary near-term goals appear to be technology development, validation, and securing initial funding.
View full company profile